J.P. Neijt

1.7k total citations
40 papers, 1.2k citations indexed

About

J.P. Neijt is a scholar working on Oncology, Reproductive Medicine and Cell Biology. According to data from OpenAlex, J.P. Neijt has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Reproductive Medicine and 11 papers in Cell Biology. Recurrent topics in J.P. Neijt's work include Cancer Treatment and Pharmacology (17 papers), Ovarian cancer diagnosis and treatment (13 papers) and Microtubule and mitosis dynamics (10 papers). J.P. Neijt is often cited by papers focused on Cancer Treatment and Pharmacology (17 papers), Ovarian cancer diagnosis and treatment (13 papers) and Microtubule and mitosis dynamics (10 papers). J.P. Neijt collaborates with scholars based in Netherlands, Germany and Italy. J.P. Neijt's co-authors include Birthe Lund, Willem Hendrik Gispen, Karen Theilade, Mads Hansen, Ole Hansen, R. Gerritsen van der Hoop, Frank P.T. Hamers, F.G.I. Jennekens, P. de Koning and Gϋnter von Minckwitz and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and British Journal of Cancer.

In The Last Decade

J.P. Neijt

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Neijt Netherlands 18 579 384 287 221 151 40 1.2k
Valeria Lucchini Italy 21 269 0.5× 199 0.5× 171 0.6× 548 2.5× 51 0.3× 36 1.3k
M. Ueda Japan 18 260 0.4× 231 0.6× 128 0.4× 549 2.5× 59 0.4× 47 1.4k
Mian M.K. Shahzad United States 22 469 0.8× 235 0.6× 125 0.4× 787 3.6× 72 0.5× 57 1.6k
Ying Xiong China 22 409 0.7× 142 0.4× 322 1.1× 529 2.4× 134 0.9× 92 1.5k
Yinyan He China 23 339 0.6× 208 0.5× 111 0.4× 613 2.8× 51 0.3× 48 1.5k
Mauricio P. Pinto Chile 20 438 0.8× 66 0.2× 322 1.1× 462 2.1× 59 0.4× 56 1.4k
Naoki Horikawa Japan 12 1.3k 2.2× 138 0.4× 112 0.4× 537 2.4× 106 0.7× 33 2.0k
Eugene T. Grygielko United States 14 207 0.4× 72 0.2× 152 0.5× 851 3.9× 59 0.4× 20 1.5k
Muriel Busson France 23 468 0.8× 85 0.2× 88 0.3× 727 3.3× 78 0.5× 35 1.4k
Yogendra P. Kharode United States 15 588 1.0× 66 0.2× 154 0.5× 1.5k 7.0× 143 0.9× 22 2.5k

Countries citing papers authored by J.P. Neijt

Since Specialization
Citations

This map shows the geographic impact of J.P. Neijt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Neijt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Neijt more than expected).

Fields of papers citing papers by J.P. Neijt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Neijt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Neijt. The network helps show where J.P. Neijt may publish in the future.

Co-authorship network of co-authors of J.P. Neijt

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Neijt. A scholar is included among the top collaborators of J.P. Neijt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Neijt. J.P. Neijt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piccart, Martine, Andreas du Bois, M. Gore, et al.. (2000). A new standard of care for treatment of ovarian cancer. European Journal of Cancer. 36(1). 10–12. 24 indexed citations
2.
Diest, P. J. van, et al.. (1994). Quantitative pathologic features as predictors of longterm survival in patients with advanced ovarian cancer treated with cisplatin. International Journal of Gynecological Cancer. 4(3). 174–179. 11 indexed citations
3.
Hoop, R. Gerritsen van der, Frank P.T. Hamers, J.P. Neijt, et al.. (1994). Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence. Journal of the Neurological Sciences. 126(2). 109–115. 28 indexed citations
4.
Voest, Emile E., et al.. (1993). The in vitro response of human tumour cells to desferrioxamine is growth medium dependent. Cell Proliferation. 26(1). 77–88. 16 indexed citations
5.
Kappen, Hilbert J. & J.P. Neijt. (1993). Neural network analysis to predict treatment outcome. Annals of Oncology. 4. S31–S34. 37 indexed citations
6.
Voest, Emile E., Ernst van Faassen, J.P. Neijt, Joannes J.M. Marx, & B. Sweder van Asbeck. (1993). Doxorubicin‐mediated free radical generation in intact human tumor cells enhances nitroxide electron paramagnetic resonance absorption intensity decay. Magnetic Resonance in Medicine. 30(3). 283–288. 3 indexed citations
7.
Vries, Elisabeth G.E. de, Thomas C. Hamilton, M. Lind, et al.. (1993). Drug resistance, supportive care and dose intensity. Annals of Oncology. 4. S57–S62. 11 indexed citations
8.
Voest, Emile E., J.P. Neijt, J. E. E. Keunen, et al.. (1993). Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity. Cancer Chemotherapy and Pharmacology. 31(5). 357–362. 20 indexed citations
9.
Voest, Emile E., Ernst van Faassen, B. Sweder van Asbeck, J.P. Neijt, & Joannes J.M. Marx. (1992). Increased hydrogen peroxide concentration in human tumor cells due to a nitroxide free radical. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1136(2). 113–118. 27 indexed citations
10.
Neijt, J.P.. (1992). Treatment of advanced ovarian cancer: 10 years of experience. Annals of Oncology. 3(1). 17–27. 23 indexed citations
11.
Leeuwenkamp, Oscar, J.P. Neijt, W. J. F. van der Vijgh, & H. M. Pinedo. (1991). Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate. European Journal of Cancer and Clinical Oncology. 27(10). 1243–1247. 29 indexed citations
12.
Graeff, Alexander de, et al.. (1991). Continuous infusion of 5-fluorouracil in ovarian cancer patients refractory to cisplatin and carboplatin. Annals of Oncology. 2(9). 691–692. 2 indexed citations
13.
Hoop, R. Gerritsen van der, et al.. (1990). Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin. Cancer. 66(8). 1697–1702. 88 indexed citations
14.
Leeuwenkamp, Oscar, W. J. F. van der Vijgh, J.P. Neijt, & Herbert M. Pinedo. (1990). Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Cancer Chemotherapy and Pharmacology. 27(2). 111–114. 10 indexed citations
15.
Willemse, P.H.B., Ate van der Gaast, J.P. Neijt, et al.. (1990). Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results. Cancer Chemotherapy and Pharmacology. 26(S1). S51–S54. 12 indexed citations
16.
Sijens, Paul E., Cees J. A. van Echteld, J J W Lagendijk, et al.. (1990). 31P NMR study of cisplatin‐ and doxorubicininduced changes in tumour metabolism in rats with a cisplatin‐sensitive or ‐resistant immunocytoma. NMR in Biomedicine. 3(3). 124–131. 2 indexed citations
17.
Sijens, Paul E., et al.. (1989). 31P NMR Study of the Impact of Dietary Manipulation on Tumor Metabolism and Response to Methotrexate. NMR in Biomedicine. 2(1). 12–18. 6 indexed citations
18.
Huinink, W.W. ten Bokkel, A.T. van Oosterom, J.P. Neijt, et al.. (1988). Carboplatin in combination therapy for ovarian cancer. Cancer Treatment Reviews. 15. 9–15. 39 indexed citations
19.
Hoop, R. Gerritsen van der, P. de Koning, Epie Boven, et al.. (1988). Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. European Journal of Cancer and Clinical Oncology. 24(4). 637–642. 70 indexed citations
20.
Koning, P. de, J.P. Neijt, F.G.I. Jennekens, & Willem Hendrik Gispen. (1987). Org.2766 protects from cisplatin-induced neurotoxicity in rats. Experimental Neurology. 97(3). 746–750. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026